STRO

Sutro Biopharma, Inc.

4.71 USD
+0.38 (+8.78%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Sutro Biopharma, Inc. stock is up 5.61% since 30 days ago. The next earnings date is Mar 28, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 February’s closed higher than January.

About Sutro Biopharma, Inc.

Sutro Biopharma, Inc. focuses on creating protein therapeutics for cancer and autoimmune disorders. The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma.